X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

August 14, 2020

How the FDA PFDD initiative is bringing the patients voice earlier into drug development

In the biologics space, there are clear trends toward higher delivery volumes, less frequent dosing, and the conversion from intravenous to subcutaneous delivery. This is driving demand for wearable technologies. Read more below about the FDA’s Patient-Focused Drug Development (PFDD) Initiative and how these findings can enable more insightful patient offerings.
Victoria Morgan

Victoria Morgan

Global Director, Segment Marketing

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    Stoppers

    August 03, 2020

    Elastomer Stoppers – Performance

    Mary Tan

    Mary Tan

    Specialist, Scientific Affairs, Jurong

    LGBTQ Community and Pride Month

    June 24, 2020

    West’s Support of the LGBTQ Community and Pride Month

    Elizabeth Crawford

    Beth Crawford

    Associate Specialist, Global Communications

    Janet Cooper and Journey

    May 20, 2020

    Volunteer Spotlight: Janet Cooper

    Elizabeth Crawford

    Elizabeth Crawford

    Associate Specialist, Global Communications

    Introducing Integrated Solutions

    May 15, 2020

    Speed to Market with a Platform Approach

    Fran DeGrazio

    Fran DeGrazio

    Chief Scientific Officer, Scientific Affairs

    By Your Side Community

    April 01, 2020

    West Stands by Your Side During Challenging Times

    West Pharma

    Valerie Bomberger

    Director, Marketing Communications and Public Relations

    Load more